Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
stroke
Biotech
Racing BMS and J&J, Bayer ties asundexian to 26% stroke decrease
The readout sets the bar for Bristol Myers Squibb and Johnson & Johnson in a blockbuster indication ahead of data on their rival factor XIa inhibitor.
Nick Paul Taylor
Feb 5, 2026 12:15pm
ARPA-H aims to fund autonomous stroke-treating robots
Nov 26, 2025 1:13pm
J&J MedTech bolsters stroke R&D programs in Ireland
Nov 24, 2025 2:20pm
Bayer's asundexian cuts stroke risk in phase 3
Nov 24, 2025 6:25am
Ventyx's CV drug rapidly reduces cardio risk biomarker
Oct 23, 2025 9:45am
Stryker, Siemens Healthineers team up for stroke-treating robot
Sep 18, 2025 11:30am